Member Contact: Thomas Ulmer
Position: Chief Financial Officer
Industry: Medtech & Digital
Global Kinetics Corporation is committed to improving the lives of those with Parkinson’s disease and other movement disorders with advanced medical technologies.
Its lead product, the Parkinson\'s KinetiGraph™ (PKG™), has been developed by neurologists at the world-renowned Florey Institute of Neuroscience in Melbourne, to enable the precise monitoring, quantification and reporting of movement symptoms of neurological diseases.